Connect
MJA
MJA

Determining the sample size in a clinical trial

Owen D Williamson
Med J Aust 2003; 178 (7): . || doi: 10.5694/j.1326-5377.2003.tb05240.x
Published online: 7 April 2003

To the Editor: Evidence-based medicine should be supported by randomised controlled trials (RCTs) that show the efficacy of interventions in producing clinically relevant outcomes, not by those that show statistically significant, but clinically irrelevant, differences.




Correspondence: 

  • 1. Kirby A, Gebski V, Keech AC. Determining the sample size in a clinical trial. Med J Aust 2002; 177: 256-257. <eMJA full text>
  • 2. Phillips R, Ball C, Sackett DL, et al. Levels of evidence and grades of recommendations. Centre for Evidence-Based Medicine, Oxford, UK. Available at http://www.indigojazz.co.uk/cebm/levels_of_evidence.asp (accessed Dec 2002).
  • 3. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting or randomized controlled trials: The CONSORT statement. JAMA 1996; 276: 637-639.
  • 4. Moher D, Schulz KF, Altman D, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285: 1987-1991.
  • 5. Keech AC, Gebski V. Managing the resource demands of a large sample size in clinical trials: can you succeed with fewer subjects? Med J Aust 2002; 177: 445-447. <eMJA full text>

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.